Mauna Kea Technologies Stock (OTC: MKEAF)

Latest news for Mauna Kea Technologies (OTC:MKEAF) Stock

Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABEO

ADAP

ADTR

ADXS

AETUF

AGHI

ALKS

AMGDF

ARGGY

ASMB

ASNA

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATRA

AVRI

AXAS

BCEFF

BCEL

BDIC

BEWFF

BGFV

BIEI

BJCHY

BJRI

BKRIF

BKUT

BLIN

BMYMP

BNDSF

BNDSY

BNIKF

BOTH

BRSWQ

CAIXY

CARB

CBGPY

CBIS

CDEV

CEIX

CESDF

CGLDF

CHKDG

CINR

CLUB

CLVS

CMSQY

CNKEF

COIHF

CORV

China Shenhua Energy Unsponsored representing A shares

CSUAY

CTRA

CUAEF

Changyou Limited American Depositary Share

CYOU

CYTX

DBLVF

DCTH

DKGH

DLTH

DMIFF

DNJR

DPDW

DPGYF

DVAX

ETRN

EVAHF

EXPR

FCUUF

FELP

FNJN

FOMX

FPLSF

FRAC

FURGF

FVANF

GARB

GNFT

GPOR

GTHR

Stocks That Managed to Breach 52-Week Lows Friday

MAUNA KEA TECHS NOM CATE by Mauna Kea Technologies

Mauna Kea Technologies SA

<a href="https://cointelegraph.com/news/china-aims-to-separate-nfts-from-crypto-via-new-blockchain-infrastructure?utm_source=dlvr.it&amp;utm_medium=twitter">https://cointelegraph.com/news/china-aims-to-separate-nfts-from-crypto-via-new-blockchain-infrastructure?utm_source=dlvr.it&amp;utm_medium=twitter</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

CRTD

DLPN

FNKO

GIGM

GRNQ

HOFV

KUKE

MKEAF

MUDS

PLBY

SRAX

TAOP

TKAT

ZKIN

Watching Non-Fungible Token Names As Traders Circulate Earlier News China Plans To Separate NFTs From Crypto Via New Blockchain Infrastructure

AMERICAN HELIUM INC by American Helium Inc.

AHELF

AIBRF

ALBHF

CANNABIS ONE HLDGS INC by Cannabis One Holdings Inc.

CAAOF

CFPUF

Mauna Kea Technologies (OTC: <a class="ticker" href="/stock/mkeaf#OTC">MKEAF</a>) announced today it has obtained a 
 510(k) regulatory clearance from the U.S. Food &amp; Drug Administration 
 (FDA) for Cellvizio in the field&hellip;
 Mauna Kea Technologies (OTC: <a class="ticker" href="/stock/mkeaf#OTC">MKEAF</a>) announced today it has obtained a 
 510(k) regulatory clearance from the U.S. Food &amp; Drug Administration 
 (FDA) for Cellvizio in the field of urology. The clearance covers the 
 use of, Cellvizio's Uroflex™ B and CystoFlex™ F Confocal Miniprobes 
 within anatomical tracts including but not limited to urethra, bladder, 
 and ureter, accessed through an endoscope or endoscopic accessories.
 This new clearance positions Mauna Kea's Cellvizio optical biopsy 
 technology for use in a range of urology applications including bladder 
 imaging during cystoscopy as well as the ureters, where traditional 
 biopsies are very difficult to perform and have
 <a href="http://www.benzinga.com/pressreleases/14/03/b4367478/mauna-kea-technologies-receives-510-k-regulatory-clearance-from-u-s-fda">See full press release</a>

Guidance

Global

Mauna Kea Technologies Receives 510(k) Regulatory Clearance from U.S. FDA for Cellvizio in Urology

Mauna Kea Technologies

<a href="https://cointelegraph.com/news/china-aims-to-separate-nfts-from-crypto-via-new-blockchain-infrastructure?utm_source=dlvr.it&amp;utm_medium=twitter">https://cointelegraph.com/news/china-aims-to-separate-nfts-from-crypto-via-new-blockchain-infrastructure?utm_source=dlvr.it&amp;utm_medium=twitter</a>

Mauna Kea Technologies (OTC: <a class="ticker" href="/stock/mkeaf#OTC">MKEAF</a>) announced today it has obtained a 
 510(k) regulatory clearance from the U.S. Food &amp; Drug Administration 
 (FDA) for Cellvizio in the field&hellip;
 
 Mauna Kea Technologies (OTC: <a class="ticker" href="/stock/mkeaf#OTC">MKEAF</a>) announced today it has obtained a 
 510(k) regulatory clearance from the U.S. Food &amp; Drug Administration 
 (FDA) for Cellvizio in the field of urology. The clearance covers the 
 use of, Cellvizio's Uroflex™ B and CystoFlex™ F Confocal Miniprobes 
 within anatomical tracts including but not limited to urethra, bladder, 
 and ureter, accessed through an endoscope or endoscopic accessories.
 
 
 This new clearance positions Mauna Kea's Cellvizio optical biopsy 
 technology for use in a range of urology applications including bladder 
 imaging during cystoscopy as well as the ureters, where traditional 
 biopsies are very difficult to perform and have
 
 <a href="http://www.benzinga.com/pressreleases/14/03/b4367478/mauna-kea-technologies-receives-510-k-regulatory-clearance-from-u-s-fda">See full press release</a>

Comments

Mauna Kea Technologies

News

Latest news for Mauna Kea Technologies (OTC:MKEAF) Stock

Thursday, January 13, 2022

Friday, July 26, 2019

Wednesday, March 05, 2014

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga